ORAGENICS, INC. Proceeds from Sale of Productive Assets
ORAGENICS, INC. (OGEN) reported Proceeds from Sale of Productive Assets of $2.20 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2016-11-14
- 2016-09-30: Proceeds from Sale of Productive Assets 9 month $2.20K.
- 2015-09-30: Proceeds from Sale of Productive Assets 9 month $1.28K.
| Period end | Proceeds from Sale of Productive Assets 9 month |
|---|---|
| 2016-09-30 | $2.20K 10-Q · filed 2016-11-14 |
| 2015-09-30 | $1.28K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |